The EMBO Journal
 
Advanced search
Journal home
Current issue
Advance Online Publication
Web Focuses
Archive
Browse by subject
Free online sample issue
Aims and scope
Press releases
ToC by email
Authors & Referees
Guide for authors
Submit an Article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Membranes & Transport | Differentiation & Death
The EMBO Journal (2006) 25, 2287–2296, doi:10.1038/sj.emboj.7601126
Published online 27 April 2006
Bcl-2 changes conformation to inhibit Bax oligomerization
Paulina J Dlugosz1, Lieven P Billen1, Matthew G Annis1, Weijia Zhu1, Zhi Zhang3, Jialing Lin3, Brian Leber1, 2 and David W Andrews1
1 Department of Biochemistry and Biomedical Sciences, McMaster University Health Sciences Centre, CDN-Hamilton, Ontario, Canada
2 Department of Medicine, McMaster University Health Sciences Centre, CDN-Hamilton, Ontario, Canada
3 Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

To whom correspondence should be addressed
David W Andrews, Department of Biochemistry and Biomedical Sciences, McMaster University Health Sciences Centre, 4H41B-1200 Main Street West, CDN-Hamilton, Ontario, Canada L8N 3Z5. Tel.: +1 905 525 9140 ext 22075; Fax: +1 905 522 9033; E-mail: andrewsd@mcmaster.ca

Received 3 November 2005; Accepted 11 April 2006; Published online 27 April 2006.
Abstract
Bcl-2 inhibits apoptosis by regulating the release of cytochrome c and other proteins from mitochondria. Oligomerization of Bax promotes cell death by permeabilizing the outer mitochondrial membrane. In transfected cells and isolated mitochondria, Bcl-2, but not the inactive point mutants Bcl-2-G145A and Bcl-2-V159D, undergoes a conformation change in the mitochondrial membrane in response to apoptotic agonists such as tBid and Bax. A mutant Bcl-2 with two cysteines introduced at positions predicted to result in a disulfide bond that would inhibit the mobility of alpha5–alpha6 helices (Bcl-2-S105C/E152C) was only active in a reducing environment. Thus, Bcl-2 must change the conformation to inhibit tBid-induced oligomerization of integral membrane Bax monomers and small oligomers. The conformationally changed Bcl-2 sequesters the integral membrane form of Bax. If Bax is in excess, apoptosis resumes as Bcl-2 is consumed by the conformational change and in complexes with Bax. Thus, Bcl-2 functions as an inhibitor of mitochondrial permeabilization by changing conformation in the mitochondrial membrane to bind membrane-inserted Bax monomers and prevent productive oligomerization of Bax.
Keywords: apoptosis, Bax, Bcl-2, membrane topology, tBid
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2006 by the European Molecular Biology Organization